The approvals strengthen India’s position as a reliable supplier of advanced pharmaceuticals across ASEAN markets where Venus Remedies already exports more than 374 products. Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), among the 10 leading fixed-dosage injectable manufacturers in the world, has secured new marketing authorizations
